A 30 Years Old Female Recovered From Shaqeeqa (Migraine) With Unani Formulation: A Case Study

Authors

  • Md Shafat Karim
  • Razia Sultana
  • Suraiya Ibrar
  • Md Najibur Rahman

Keywords:

Migraine, Shaqeeqa, Unani Medicine, Suda’a, Headache

Abstract

Background: Recurrent unilateral, throbbing headaches of moderate to severe intensity, frequently accompanied by nausea, photophobia, and phonophobia, are the hallmarks of migraine, a common and incapacitating primary headache disease. 15.2% of people worldwide suffer from migraines, which are a major contributor to years spent disabled, especially for women. A full remedy is still unknown despite significant progress in both conventional and modern medicine. According to Unani medicine, migraines (shaqeeqa) are caused by either a buildup of gaseous and viscous substances in the head or temperamental imbalances.

Case Study: This case study presents a 35-year-old female with chronic migraine unresponsive to modern medication, who was treated with a traditional Unani compound formulation containing Ustukhuddus (Lavandula stoechas L.) flowers, Filfil Siyah (Piper nigrum Linn.) seeds, Kishniz khushk (Coriandrum sativum Linn.) seeds, and Misri (sugar candy).

Results: After 40 days of daily administration, the patient reported complete resolution of nausea, a significant reduction in headache severity (VAS score reduced from 6–7 to 1–2), and decreased frequency of migraine episodes.

Discussion: The therapeutic effects of the compound formulation are attributed to the neuroprotective, sedative, anti-inflammatory, and carminative properties of the ingredients, as described in Unani medicine. This case supports the potential efficacy of Unani compound formulations in migraine management, highlighting the need for further research to validate these findings in larger populations.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

.Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013 Jul;33(9):629–808.

.Raggi A, Leonardi M, Arruda M, Caponnetto V, Castaldo M, Coppola G, et al. Hallmarks of primary headache: part 1 – migraine. J Headache Pain. 2024 Oct 31;25(1):189.

Dong L, Dong W, Jin Y, Jiang Y, Li Z, Yu D. The Global Burden of Migraine: A 30-Year Trend Review and Future Projections by Age, Sex, Country, and Region. Pain Ther. 2025 Feb;14(1):297–315.

.Xu R, Zhang R, Dong L, Xu X, Fan X, Zhou J. An analysis of the burden of migraine and tension-type headache across the global, China, the United States, India and Japan. Front Pain Res (Lausanne). 2025 Feb 3;6:1539344. doi: 10.3389/fpain.2025.1539344.

.Jilani G. Makhzan-e-Hikmat. New Delhi: Idara Kitab -us-Shifa; YNM.712 p.

.Tabri AHA. Al-Moalajat-e-Boqratia. New Delhi: Central Council for Research in Unani Medicine (CCRUM); 1995. 284 p.

.Khan MA. Akseer-e-Azam. (Urdu Translation. Kabeeruddin M.) Ed. 1st. New Delhi: Idara Kitab -us-Shifa; 2011. 77 p.

.Kalam A, M, Husain Z, Haseeb A, Husain S, Shah K, Saleem B. Ustukhuddus (Lavandula stoechas L.): A Boon for the Management of Neuropsychiatric Disorders in Perspective of Unani Medicine-A Review. Acta Sci Pharm Sci. 2021 Feb 27;5(3):02–9.

.Khan A. Moheet-i-Azam. Volu-1st, Vol-3rd, Vol-4th, Part-1. New Delhi: Central Council for Research in Unani Medicine (CCRUM);2012, 2014, 2018. 199, 307, 720 p.

Hakeem AH. Bustan-Ul- Mufradat. New Delhi: Idara Kitab -us-Shifa; 2002. 67, 282 p.

Ghani N. Khazainul Advia. Part-1, 3rd Ed. New Delhi: Idara Kitab -us-Shifa; 2011. 226, 972 p.

.Yasir M, Khanam T, Hafeel M,H.M. ‘A- review on Kishneez (Coriander Sativum Linn.): A Potential herb. The Pharma Innovation Journal 2019; 8(9): 503-506.

.Sobhani Z, Mohtashami L, Amiri MS, Ramezani M, Emami SA, Simal‐Gandara J. Ethnobotanical and phytochemical aspects of the edible herb Coriandrum sativum L. J Food Sci. 2022 Apr;87(4):1386–422.

.Jan U, Kalam MohdA, Wani NN, Ayoub M, Farooq SF, Yaqoob F. Filfil Siyāh (Piper nigrum): Medicinal importance in perspective of Unani medicine and pharmacological studies. J Pharmacogn Phytochem. 2024 Jan 1;13(2):652–6.

.Mao QQ, Huang Z, Ip SP, Xian YF, Che CT. Protective effects of piperine against corticosterone-induced neurotoxicity in PC12 cells. Cell Mol Neurobiol. 2012 May;32(4):531.

Downloads

Published

2025-08-18

How to Cite

1.
Karim MS, Sultana R, Ibrar S, Rahman MN. A 30 Years Old Female Recovered From Shaqeeqa (Migraine) With Unani Formulation: A Case Study. J Neonatal Surg [Internet]. 2025Aug.18 [cited 2025Sep.20];14(9S):1014-6. Available from: https://jneonatalsurg.com/index.php/jns/article/view/8900